Anal cancer in HIV patients

被引：2

作者：

Quero, Laurent ^{[1
]}

Duval, Xavier ^{[2
]}

Abramowitz, Laurent ^{[3
]}

机构：

[1] Hop St Louis, AP HP, Serv Cancerol Radiotherapie, F-75010 Paris, France

[2] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, F-75018 Paris, France

[3] Hop Bichat Claude Bernard, AP HP, Serv Gastroenterol, F-75018 Paris, France

来源：

BULLETIN DU CANCER | 2014年 / 101卷 / 11期

关键词：

HIV; cancer; anal; review; SQUAMOUS-CELL CARCINOMA; HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTED PATIENTS; POSITIVE PATIENTS; PROTEASE INHIBITORS; RADIATION-THERAPY; OUTCOMES; ERA; CHEMORADIOTHERAPY; RADIOSENSITIVITY;

D O I：

10.1684/bdc.2014.2035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Despite effective highly active antiretroviral treatment, anal cancer incidence has recently strongly increased in HIV-infected population. Treatment strategy in HIV-infected patients does not differ from general population. HIV-infected patients treated by chemo-radiotherapy are exposed to high-grade toxicities and should be closely monitored to deliver the optimal treatment. Close collaboration between oncologist and infectiologist is highly recommended to adjust antiretroviral therapy if necessary.

引用

页码：1034 / 1039

页数：6

共 38 条

[1] Economic burden of anal cancer management in France [J].

Abramowitz, L. ;

Remy, V. ;

Vainchtock, A. .

REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2010, 58 (05) :331-338

[2] Epidermoid anal cancer prognosis comparison among HIV plus and HIV- patients [J].

Abramowitz, L. ;

Mathieu, N. ;

Roudot-Thoraval, F. ;

Lemarchand, N. ;

Bauer, P. ;

Hennequin, C. ;

Mitry, E. ;

Romelaer, C. ;

Aparicio, T. ;

Sobhani, I. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (04) :414-421

[3] Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study [J].

Abramowitz, Laurent ;

Jacquard, Anne-Carole ;

Jaroud, Fatiha ;

Haesebaert, Julie ;

Siproudhis, Laurent ;

Pradat, Pierre ;

Aynaud, Olivier ;

Leocmach, Yann ;

Soubeyrand, Benoit ;

Dachez, Roger ;

Riethmuller, Didier ;

Mougin, Christiane ;

Pretet, Jean-Luc ;

Denis, Francois .

INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (02) :433-439

[4] Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression [J].

Alfa-Wali, M. ;

Allen-Mersh, T. ;

Antoniou, A. ;

Tait, D. ;

Newsom-Davis, T. ;

Gazzard, B. ;

Nelson, M. ;

Bower, M. .

ANNALS OF ONCOLOGY, 2012, 23 (01) :141-U473

[5]

[Anonymous], 2013, PRISE CHARGE MED PER

[6] Risk Factors for Anal Cancer in Persons Infected With HIV: A Nested Case-Control Study in the Swiss HIV Cohort Study [J].

Bertisch, Barbara ;

Franceschi, Silvia ;

Lise, Mauro ;

Vernazza, Pietro ;

Keiser, Olivia ;

Schoeni-Affolter, Franziska ;

Bouchardy, Christine ;

Dehler, Silvia ;

Levi, Fabio ;

Jundt, Gernot ;

Ess, Silvia ;

Pawlita, Michael ;

Kovari, Helen ;

Wandeler, Gilles ;

Calmy, Alexandra ;

Cavassini, Matthias ;

Stoeckle, Marcel ;

Clifford, Gary .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (06) :877-884

[7] Anal carcinomas in HIV-positive patients:: High-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy [J].

Blazy, A ;

Hennequin, C ;

Gornet, JM ;

Furco, A ;

Gérard, L ;

Lémann, M ;

Maylin, C .

DISEASES OF THE COLON & RECTUM, 2005, 48 (06) :1176-1181

[8] Phase I trial of the human immunodeficiency virus protease inhibitor Nelfinavir and chemoradiation for locally advanced pancreatic cancer [J].

Brunner, Thomas B. ;

Geiger, Matthias ;

Grabenbauer, Gerhard G. ;

Lang-Welzenbach, Marga ;

Mantoni, Tine S. ;

Cavallaro, Alexander ;

Sauer, Rolf ;

Hohenberger, Werner ;

McKenna, W. Gillies .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) :2699-2706

[9]

Chuong Michael D, 2013, Gastrointest Cancer Res, V6, P39

[10] Treatment of HIV-associated invasive anal cancer with combined chemoradiation [J].

Cleator, S ;

Fife, K ;

Nelson, M ;

Gazzard, B ;

Phillips, R ;

Bower, M .

EUROPEAN JOURNAL OF CANCER, 2000, 36 (06) :754-758

← 1 2 3 4 →